查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美腦植入物市場預測至 2030 年 - 區域分析 - 按治療、應用和最終用戶（醫院和專科診所/神經中心）
市場調查報告書
商品編碼
1494298

北美腦植入物市場預測至 2030 年 - 區域分析 - 按治療、應用和最終用戶（醫院和專科診所/神經中心）

North America Brain Implants Market Forecast to 2030 - Regional Analysis - by Treatment, Application, and End User (Hospitals and Specialized Clinics/Neurological Centers)
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 訂單完成後即時交付

價格

2022年北美腦植入市場價值為31.3197億美元，預計到2030年將達到77.6872億美元；預計2022年至2030年複合年成長率為12.0%。

隨著老年人口的增加，神經系統疾病的盛行率激增，推動了北美腦植入市場的發展

隨著年齡的成長，老年人可能會出現影響其活動能力的神經系統疾病。阿茲海默症、癲癇、帕金森氏症 (PD) 和肌張力失調是影響老年族群最常見的神經系統疾病。根據美國人口普查局2020年人口統計，老年人口達5,580萬，佔全國人口的16.8%； 2020年，加拿大近六分之一的人口年齡在65歲及以上。 ，預計到 2030 年將達到 22.5%。

美國和加拿大等國家與老年人口成長相關的運動障礙和精神疾病盛行率很高。根據帕金森基金會的數據，帕金森症狀在平均 60 歲的人群中很常見。該組織也指出，帕金森氏症的發生率隨著年齡的成長而增加；美國有近100 萬人患有帕金森氏症，預計到2030 年這一數字將達到120 萬人。的文章，約3200 萬人患有帕金森氏症全世界都患有阿茲海默症。根據 BrightFocus 基金會 2022 年 10 月發布的阿茲海默症研究情況說明書，2022 年美國診斷出約 50 萬例新阿茲海默症病例。阿茲海默症的發生率隨著年齡的成長而增加。約650 萬65 歲及以上的美國人患有阿茲海默症，預計到2050 年這一數字將達到1,270 萬人。根據世界衛生組織(WHO) 2022 年2 月發布的統計數據，約有5,000 萬。人類患有癲癇症，其中是全世界最常見的神經系統疾病之一。

神經系統疾病發生率的不斷增加，加上老年人口的不斷成長，推動了對大腦植入物治療和控制疾病的需求。深部腦部刺激（DBS）技術用於治療癲癇病例，因為患者的身體在癲癇發作期間對藥物的治療反應較低，且與手術相關的成功率降低。北卡羅來納大學教堂山分校的研究人員聲稱已經在大腦中產生了新的神經元，可以使用 DBS 來刺激這些神經元。阿茲海默症的 DBS 涉及利用類似心臟起搏器的植入裝置和兩根連接線，將溫和的電脈衝直接傳遞到大腦的穹窿區域。電刺激可以活化大腦中的記憶電路，並增強其功能。因此，DBS 和迷走神經刺激等神經植入物擴大用於治療帕金森氏症和其他神經系統疾病患者。

北美腦植入市場概況

北美腦植入市場分為美國、加拿大和墨西哥。 2022年，美國在該地區佔據最大市場佔有率，預計在預測期內將繼續保持主導地位。帕金森氏症(PD) 等神經系統疾病的盛行率不斷上升、人們對神經系統疾病的認知不斷增強、積極的研究成果以及開發各種刺激器的投資不斷增加，是推動美國腦植入物整體市場成長的主要因素。根據帕金森基金會的數據，2020 年美國有93 萬人患有帕金森氏症，預計到2030 年這一數字將增加到120 萬人。證明是潛在的治療選擇對於PD。據觀察，DBS 裝置可有效控制與 PD 相關的震顫。根據美國俄勒岡健康與科學大學 (OSHU) 腦研究所的數據，約 90% 的原發性震顫患者在接受 DBS 治療後症狀適度緩解。

根據2022 年3 月發表的一項題為「2022 年阿茲海默症事實與數據」的研究，到2022 年，約650 萬65 歲及以上的美國人被發現患有阿茲海默症，預計到2060 年，這一數字將增至1380 萬。 2023 年 3 月，密西根理工大學的研究人員使用神經形態運算來提高用於治療 PD 的 DBS 系統的功效和能源效率。同樣，北卡羅來納大學教堂山分校的研究人員發現，他們能夠在大腦中產生新的神經元，並使用 DBS 刺激它們。這個過程有助於恢復患有阿茲海默症的小鼠模型的認知和非認知功能。

技術進步和新產品推出推動了美國腦植入物市場的成長。 2020 年 1 月，雅培的 Infinity DBS 系統獲得美國食品藥物管理局 (FDA) 批准用於治療帕金森氏症。該系統針對大腦的特定區域（蒼白球內部），該區域與帕金森氏症的症狀相關。 2020 年 9 月，波士頓科學公司宣佈在歐洲推出 WaveWriter Alpha SCS 系統產品組合。 2023 年 5 月，雅培公司的脊髓刺激器 (SCS) 裝置獲得美國 FDA 批准，用於治療不建議接受背部手術的人的慢性背痛。 2023 年 9 月，Neuralink 獲得獨立審查委員會的批准，開始招募針對癱瘓患者的腦植入物的首次人體試驗。該研究將使用機器人透過手術將腦機介面（BCI）植入物植入大腦控制身體運動的區域。

因此，神經系統疾病盛行率的增加、研發活動的增加以及腦植入物的技術進步預計將推動未來腦植入物市場的成長。

北美腦植入市場收入及 2030 年預測（百萬美元）

北美腦植入市場細分

北美腦植入市場分為治療、應用、最終用戶和國家。

根據治療方式，北美腦植入物市場分為深部腦部刺激器、脊髓刺激器、迷走神經刺激器、侵入性和非侵入性腦機介面、癲癇反應性神經刺激器、聽覺腦幹植入物和眼科輔助/植入物。此外，聽覺腦幹植入段分為耳蝸後聽力障礙和耳蝸聽力障礙。 2022 年，脊髓刺激領域佔最大佔有率。

從應用來看，北美腦植入市場分為慢性疼痛、巴金森氏症、阿茲海默症、癲癇、原發性震顫、憂鬱症、肌張力失調、肌萎縮性側索硬化症（ALS）和神經纖維瘤病2。

根據最終用戶，北美腦植入市場分為醫院和專科診所/神經中心。 2022 年，醫院細分市場佔最大佔有率。

依國家/地區分類，北美腦植入市場分為美國、加拿大和墨西哥。 2022年，美國在北美腦植入市場佔據主導地位。

Abbott Laboratories、Blackrock Microsystems Inc、Boston Scientific Corp、BrainGate、Fisher Wallace Laboratories Inc、Functional Neuromodulation Ltd、Medtronic Plc、Neuralink Corp、NeuroPace Inc、NeuroSky Inc、Neurospine LLC、ONWARD Medical NV、Paradromics Inc.北美腦植入市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美腦植入市場格局

  • 概述
  • 北美 PEST 分析

第 5 章：北美腦植入市場 - 主要產業動態

  • 主要市場促進因素
    • 隨著老年人口的增加，神經系統疾病的盛行率激增
    • 脊髓損傷數量不斷增加
  • 主要市場限制
    • 與腦植入設備和程序相關的高成本
  • 主要市場機會
    • 公司的策略舉措
  • 未來主要趨勢
    • 小型化、人工智慧和現代腦機介面等技術進步
  • 影響分析：

第 6 章：腦植入市場 - 北美市場分析

  • 概述
  • 北美腦植入市場收入，2022 - 2030

第 7 章：北美腦植入市場 - 收入和 2030 年預測 - 按治療方法

  • 概述
  • 2022 年和 2030 年北美腦植入市場收入佔有率（按治療方式）（%）
  • 深部腦部刺激
  • 脊髓刺激
  • 迷走神經刺激器
  • 侵入式和非侵入式腦機介面
  • 癲癇發作的反應性神經刺激
  • 聽覺腦幹植入物
  • 眼科輔助器具/植入物

第 8 章：北美腦植入市場 - 2030 年收入與預測 - 按應用

  • 概述
  • 2022 年和 2030 年北美腦植入市場收入佔有率，按應用分類 (%)
  • 慢性疼痛
  • 帕金森氏症
  • 阿茲海默氏症
  • 癲癇
  • 特發性震顫
  • 沮喪
  • 肌張力失調
  • 肌萎縮側索硬化症
  • 神經纖維瘤病2

第 9 章：北美腦植入市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年北美腦植入市場收入佔有率（按最終用戶分類）（%）
  • 醫院
  • 專科診所/神經內科中心

第 10 章：北美腦植入市場 - 地理分析

  • 北美 北美腦植入市場，依主要國家收入分類（2022 年）
      • 北美 北美腦植入市場，依國家分類
      • 美國
      • 加拿大
      • 墨西哥

第 11 章：腦植入市場-產業格局

  • 概述
  • 腦植入市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Boston Scientific Corp
  • Medtronic Plc
  • Functional Neuromodulation Ltd
  • Fisher Wallace Laboratories Inc
  • Synchron Inc
  • Blackrock Microsystems Inc
  • Renishaw Plc
  • Abbott Laboratories
  • Neurospine LLC
  • BrainGate
  • NeuroSky Inc
  • Neuralink Corp
  • NeuroPace Inc
  • ONWARD Medical NV
  • Paradromics Inc

第 13 章：附錄

Product Code: BMIRE00029805

The North America brain implants market was valued at US$ 3,131.97 million in 2022 and is expected to reach US$ 7,768.72 million by 2030; it is estimated to grow at a CAGR of 12.0% from 2022 to 2030.

Surging Prevalence of Neurological Disorders with Increasing Geriatric Population Fuels North America Brain Implants Market

With age, elderly people are likely to develop neurological disorders that impact their mobility. Alzheimer's disease, epilepsy, Parkinson's disease (PD), and dystonia are among the most common neurological disorders affecting the geriatric population. According to the 2020 population statistics by the US Census Bureau, the geriatric population reached 55.8 million, i.e., 16.8% of the national population; nearly 1 in 6 people in the country were aged 65 and above in 2020. Further, as per the data published by the Fraser Institute, the share of Canada's population aged 65 or older increased from 14% in 2010 to 19% in 2022 and is expected to reach 22.5% by 2030. According to an article published by UpToDate Inc. in August 2021, the incidence rate of epilepsy rises with age and is highest among patients aged 75 and above.

Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. For instance, ~90,000 Americans are diagnosed with PD yearly. The organization also states that the incidence of PD increases with age; nearly 1 million people in the US are living with PD, and the number is expected to reach 1.2 million by 2030. According to an article titled "Alzheimer's disease: Can deep brain stimulation help alleviate symptoms" published in April 2023, ~32 million people worldwide have Alzheimer's disease. As per the Alzheimer's Disease Research Factsheet, published by BrightFocus Foundation in October 2022, ~500,000 new cases of Alzheimer's disease were diagnosed in 2022 in the US. The incidence rate of Alzheimer's increases with age. ~6.5 million Americans aged 65 and above are suffering from Alzheimer's disease, and the number is expected to reach 12.7 million by 2050. According to the World Health Organization (WHO) stats released in February 2022, approximately 50 million people suffer from epilepsy, which is one of the most common neurological diseases worldwide.

The increasing incidence of neurological diseases, coupled with the growing geriatric population, drives the demand for brain implants to treat and manage the disease. The deep brain stimulation (DBS) technique is used to treat epilepsy cases due to the low therapeutic response exhibited by the patient's body to medication during seizures and reduced success rates associated with surgeries. Researchers from the University of North Carolina at Chapel Hill claim to have generated new neurons in the brain, which can be stimulated using DBS. DBS for Alzheimer's involves utilizing an implanted device similar to a heart pacemaker and two attached wires that deliver mild electrical pulses directly to the fornix area of the brain. Electrical stimulation can activate the memory circuitry in the brain to sharpen its function. Thus, neural implants such as DBS and vagus nerve stimulation are increasingly being used to treat patients with PD and other neurological conditions.

North America Brain Implants Market Overview

The North America brain implants market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The increasing prevalence of neurological diseases such as Parkinson's disease (PD), growing awareness about neurological disorders, positive research results, and growing investments in developing various stimulators are among the main factors driving the overall market growth for brain implants in the US. According to the Parkinson's Foundation, 930,000 people in the US were suffering from PD in 2020, and the number is expected to increase to 1.2 million by 2030. Brain implants, such as deep brain stimulation (DBS), have proven to be potential treatment options for PD. DBS devices have been observed to be effective in controlling tremors associated with PD. As per the Oregon Health & Science University (OSHU) Brain Institute, in the US, ~90% of patients with essential tremors experienced moderate relief from symptoms after DBS.

According to a study titled "2022 Alzheimer's disease facts and figures," published in March 2022, ~6.5 million Americans aged 65 and above were found to have Alzheimer's disease in 2022, and the number is projected to rise to 13.8 million by 2060. Moreover, major market players focus on introducing new versions of DBS devices. In March 2023, researchers at Michigan Technological University used neuromorphic computing to improve the efficacy and energy efficiency of DBS systems used to treat PD. Similarly, researchers from the University of North Carolina at Chapel Hill discovered that they were able to generate new neurons in the brain and stimulate them using DBS. This process helped restore cognitive and noncognitive functions in a mouse model that had Alzheimer's disease.

Technological advancements and new product launches drive the growth of the US brain implants market. In January 2020, Abbott's Infinity DBS System received US Food and Drug Administration (FDA) approval for treating PD. This system targets a specific area of the brain (the inner globus pallidus), which is associated with the symptoms of PD. In September 2020, Boston Scientific announced the European launch of the WaveWriter Alpha portfolio of SCS systems. In May 2023, Abbott received approval from the US FDA for spinal cord stimulator (SCS) devices to treat chronic back pain in people who are not recommended to receive back surgery. In September 2023, Neuralink received approval from an independent review board to initiate recruitment for the first human trial of brain implants for paralysis patients. The study will involve a robot to surgically place a brain-computer interface (BCI) implant in the area of the brain that controls bodily movements.

Therefore, increasing prevalence of neurological diseases, rising research and development activities, and technological advancements in brain implants are expected to bolster the brain implants market growth in the future.

North America Brain Implants Market Revenue and Forecast to 2030 (US$ Million)

North America Brain Implants Market Segmentation

The North America brain implants market is segmented into treatment, application, end user, and country.

Based on treatment, the North America brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.

In terms of application, the North America brain implants market is categorized into chronic pain, Parkinson's disease, Alzheimer's disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.

Based on end user, the North America brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.

Based on country, the North America brain implants market is segmented the US, Canada, and Mexico. The US dominated the North America brain implants market in 2022.

Abbott Laboratories, Blackrock Microsystems Inc, Boston Scientific Corp, BrainGate, Fisher Wallace Laboratories Inc, Functional Neuromodulation Ltd, Medtronic Plc, Neuralink Corp, NeuroPace Inc, NeuroSky Inc, Neurospine LLC, ONWARD Medical NV, Paradromics Inc, Renishaw Plc, and Synchron Inc are some of the leading companies operating in the North America brain implants market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Brain Implants Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Brain Implants Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
    • 5.1.2 Rising Number of Spinal Cord Injuries
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost Associated with Brain Implant Devices and Procedures
  • 5.3 Key Market Opportunities
    • 5.3.1 Strategic Initiatives by Companies
  • 5.4 Key Future Trends
    • 5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
  • 5.5 Impact Analysis:

6. Brain Implants Market - North America Market Analysis

  • 6.1 Overview
  • 6.2 North America Brain Implants Market Revenue (US$ Mn), 2022 - 2030

7. North America Brain Implants Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 North America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Deep Brain Stimulation
    • 7.3.1 Overview
    • 7.3.2 Deep Brain Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Spinal Cord Stimulation
    • 7.4.1 Overview
    • 7.4.2 Spinal Cord Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Vagus Nerve Stimulator
    • 7.5.1 Overview
    • 7.5.2 Vagus Nerve Stimulator: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Invasive and Non-Invasive Brain-Computer Interfaces
    • 7.6.1 Overview
    • 7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Responsive Neurostimulation for Seizures
    • 7.7.1 Overview
    • 7.7.2 Responsive Neurostimulation for Seizures: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Auditory Brainstem Implant
    • 7.8.1 Overview
    • 7.8.2 Auditory Brainstem Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.8.2.1 Retrocochlear Hearing Impairment
        • 7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
      • 7.8.2.2 Cochlear Hearing Impairment
        • 7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Ophthalmic Aids/Implant
    • 7.9.1 Overview
    • 7.9.2 Ophthalmic Aids/Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Brain Implants Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Chronic Pain
    • 8.3.1 Overview
    • 8.3.2 Chronic Pain: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Parkinson's disease
    • 8.4.1 Overview
    • 8.4.2 Parkinson's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Alzheimer's disease
    • 8.5.1 Overview
    • 8.5.2 Alzheimer's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Epilepsy
    • 8.6.1 Overview
    • 8.6.2 Epilepsy: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Essential Tremor
    • 8.7.1 Overview
    • 8.7.2 Essential Tremor: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Depression
    • 8.8.1 Overview
    • 8.8.2 Depression: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Dystonia
    • 8.9.1 Overview
    • 8.9.2 Dystonia: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Amyotrophic Lateral Sclerosis
    • 8.10.1 Overview
    • 8.10.2 Amyotrophic Lateral Sclerosis (ALS): North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.11 Neurofibromatosis 2
    • 8.11.1 Overview
    • 8.11.2 Neurofibromatosis 2: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Brain Implants Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 North America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Specialized Clinics / Neurological Centers
    • 9.4.1 Overview
    • 9.4.2 Specialized Clinics / Neurological Centers: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Brain Implants Market - Geographical Analysis

  • 10.1 North America North America Brain Implants Market, by Key Country-Revenue (2022)
      • 10.1.1.1 North America North America Brain Implants Market, by Country
      • 10.1.1.2 US
        • 10.1.1.2.1 US: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 US: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 US: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.1.2.3 US: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4 US: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 Canada
        • 10.1.1.3.1 Canada: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Canada: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 Canada: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Canada: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Canada: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.4 Mexico
        • 10.1.1.4.1 Mexico : North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Mexico: North America Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.4.2.1 Mexico: North America Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Mexico: North America Brain Implants Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Mexico: North America Brain Implants Market, by End-User, 2020-2030 (US$ Million)

11. Brain Implants Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Brain Implants Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Boston Scientific Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Functional Neuromodulation Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 SWOT Analysis
    • 12.3.5 Key Developments
  • 12.4 Fisher Wallace Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Synchron Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 SWOT Analysis
    • 12.5.5 Key Developments
  • 12.6 Blackrock Microsystems Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 SWOT Analysis
    • 12.6.5 Key Developments
  • 12.7 Renishaw Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Abbott Laboratories
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Neurospine LLC
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 BrainGate
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 SWOT Analysis
    • 12.10.5 Key Developments
  • 12.11 NeuroSky Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 SWOT Analysis
    • 12.11.5 Key Developments
  • 12.12 Neuralink Corp
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 SWOT Analysis
    • 12.12.5 Key Developments
  • 12.13 NeuroPace Inc
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 ONWARD Medical NV
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Paradromics Inc
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 SWOT Analysis
    • 12.15.5 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Brain Implants Market Segmentation
  • Table 2. US: North America Brain Implants Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Brain Implants Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America Brain Implants Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Brain Implants Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America Brain Implants Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America Brain Implants Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico : North America Brain Implants Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico : North America Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico : North America Brain Implants Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico : North America Brain Implants Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Recent Organic Growth Strategies in Brain Implants Market
  • Table 15. Recent Inorganic Growth Strategies in the Brain Implants Market
  • Table 16. Glossary of Terms, North America Brain Implants Market

List Of Figures

  • Figure 1. North America Brain Implants Market Segmentation, By Country
  • Figure 2. North America PEST Analysis
  • Figure 3. North America Brain Implants Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Brain Implants Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 7. Deep Brain Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Spinal Cord Stimulation: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Vagus Nerve Stimulator: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Invasive and Non-Invasive Brain-Computer Interfaces: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Responsive Neurostimulation for Seizures: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Auditory Brainstem Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Retrocochlear Hearing Impairment: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cochlear Hearing Impairment: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ophthalmic Aids/Implant: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Chronic Pain: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Parkinson's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Alzheimer's disease: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Epilepsy: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Essential Tremor: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Depression: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Dystonia: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Amyotrophic Lateral Sclerosis (ALS): North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Neurofibromatosis 2: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. North America Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 27. Hospitals: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Specialized Clinics / Neurological Centers: North America Brain Implants Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America: Brain Implants Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. North America Brain Implants Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. US: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada: North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico : North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Growth Strategies in Brain Implants Market